Medicover AB (publ) (STO:MCOV.B)
238.50
-1.00 (-0.42%)
Nov 14, 2025, 5:29 PM CET
Medicover AB Revenue
Medicover AB had revenue of 591.60M EUR in the quarter ending September 30, 2025, with 12.09% growth. This brings the company's revenue in the last twelve months to 2.32B, up 16.23% year-over-year. In the year 2024, Medicover AB had annual revenue of 2.09B with 19.78% growth.
Revenue (ttm)
2.32B EUR
Revenue Growth
+16.23%
P/S Ratio
1.40
Revenue / Employee
49.14K EUR
Employees
47,256
Market Cap
36.03B SEK
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.09B | 345.40M | 19.78% |
| Dec 31, 2023 | 1.75B | 236.20M | 15.64% |
| Dec 31, 2022 | 1.51B | 132.80M | 9.64% |
| Dec 31, 2021 | 1.38B | 379.60M | 38.04% |
| Dec 31, 2020 | 997.80M | 153.40M | 18.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vimian Group AB | 4.65B |
| Vitrolife AB | 3.51B |
Medicover AB News
- 11 days ago - Medicover AB (MCVEF) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 11 days ago - Q3 2025 Medicover AB Earnings Call Transcript - GuruFocus
- 11 days ago - Medicover AB (publ) (MCVEY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Medicover AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha